Abner Herrman & Brock LLC Pfizer Inc Transaction History

Abner Herrman & Brock LLC

$829 Million
Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Pfizer Inc stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 13,750 shares of PFE stock, worth $377,575. This represents 0.05% of its overall portfolio holdings.

Number of Shares

13,750

Previous 13,950 1.43%

Holding current value

$377,575

Previous $390,000 2.05%

% of portfolio

0.05%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$27.7 - $31.39 $5,540 - $6,278	-200 Reduced 1.43%	13,750 $398,000
Q1 2024 Apr 09, 2024	BUY	$25.89 - $29.73 $29,411 - $33,773	1,136 Added 8.87%	13,950 $387,000
Q4 2023 Jan 09, 2024	BUY	$26.13 - $33.94 $32,009 - $41,576	1,225 Added 10.57%	12,814 $369,000
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $11,712 - $13,691	-365 Reduced 3.05%	11,589 $384,000
Q2 2023 Jul 05, 2023	BUY	$36.12 - $41.79 $5,092 - $5,892	141 Added 1.19%	11,954 $438,000
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $118,465 - $140,462	2,546 Added 27.47%	11,813 $619,000
Q1 2022 Apr 07, 2022	SELL	$45.75 - $56.69 $9,333 - $11,564	-204 Reduced 2.15%	9,267 $480,000
Q4 2021 Jan 13, 2022	BUY	$41.32 - $61.25 $38,179 - $56,595	924 Added 10.81%	9,471 $559,000
Q3 2021 Oct 06, 2021	SELL	$39.25 - $50.42 $4,042 - $5,193	-103 Reduced 1.19%	8,547 $368,000
Q2 2021 Jul 09, 2021	SELL	$35.91 - $40.68 $1.38 Million - $1.56 Million	-38,425 Reduced 81.63%	8,650 $339,000
Q1 2021 Apr 09, 2021	SELL	$33.49 - $37.77 $1.8 Million - $2.03 Million	-53,787 Reduced 53.33%	47,075 $1.71 Million
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $12,350 - $15,704	-369 Reduced 0.36%	100,862 $3.71 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $2.27 Million - $2.66 Million	-71,358 Reduced 41.35%	101,231 $3.72 Million
Q2 2020 Jul 10, 2020	BUY	$30.12 - $36.54 $3.38 Million - $4.11 Million	112,380 Added 186.65%	172,589 $5.64 Million
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $893,611 - $1.28 Million	33,060 Added 121.77%	60,209 $1.97 Million
Q4 2019 Jan 10, 2020	BUY	$32.92 - $37.36 $24,690 - $28,020	750 Added 2.84%	27,149 $1.06 Million
Q3 2019 Oct 11, 2019	SELL	$32.49 - $42.13 $32,425 - $42,045	-998 Reduced 3.64%	26,399 $949,000
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $39,013 - $43,803	-1,055 Reduced 3.71%	27,397 $1.19 Million
Q1 2019 Apr 08, 2019	SELL	$37.5 - $41.2 $5,287 - $5,809	-141 Reduced 0.49%	28,452 $1.21 Million
Q4 2018 Jan 11, 2019	BUY	$38.47 - $43.86 $190,695 - $217,414	4,957 Added 20.97%	28,593 $1.25 Million
Q3 2018 Oct 19, 2018	BUY	$34.47 - $41.81 $23,060 - $27,970	669 Added 2.91%	23,636 $1.04 Million
Q2 2018 Jul 06, 2018	BUY	$32.98 - $35.16 $34,661 - $36,953	1,051 Added 4.8%	22,967 $833,000
Q1 2018 Apr 06, 2018	BUY	$31.91 - $37.02 $3,222 - $3,739	101 Added 0.46%	21,916 $778,000
Q4 2017 Jan 05, 2018	BUY	$33.26 - $35.29 $166 - $176	5 Added 0.02%	21,815 $790,000
Q3 2017 Oct 06, 2017	BUY	$31.0 - $34.15 $676,110 - $744,811	21,810	21,810 $779,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Account

Abner Herrman & Brock LLC Pfizer Inc Transaction History